Q&A on HIV PrEP: Episode 3 on Adolescents and Young Adults

In this podcast, experts Sarah M. Wood, MD, MS, and Errol L. Fields, MD, PhD, MPH, discuss some of the challenges and concerns clinicians face when prescribing PrEP to adolescents. 

The faculty addresses the potential for adverse effects from PrEP, including the potential for renal impairment, decreased bone density, and whether PrEP can interfere with hormone therapy for gender-affirming care. They review the data behind these concerns and emphasize that the vast majority of adverse effects caused by PrEP are mild and reversible.

The experts also examine common barriers that adolescents face when attempting to initiate and adhere to PrEP, such as insurance coverage and confidentiality. Dr Fields and Dr Woods discuss strategies for overcoming these barriers and retaining adolescents on PrEP, including how to navigate tricky conversations with both patients and parents or within communities that may stigmatize PrEP and HIV.

Sarah M. Woods, MD, MS
Assistant Professor of Pediatrics
Division of Adolescent Medicine
University of Pennsylvania Perelman School of Medicine
Children’s Hospital of Philadelphia
Philadelphia, Pennsylvania

Errol L. Fields, MD, PhD, MPH
Associate Professor of Pediatrics
Division of Adolescent/Young Adult Medicine
Department of Pediatrics
Johns Hopkins School of Medicine
Baltimore, Maryland

Content based on an online CME program supported by independent educational grants from Gilead Sciences Inc. and ViiV Healthcare.

Link to full program: 
https://bit.ly/3PZGYdR

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.